Blocking the effect of interleukin-1 and tumor necrosis factor in rheumatoid arthritis is well tolerated and effective

ISSN： 1475-0708

Source： Therapy, Vol.1, Iss.2, 2004-11, pp. : 255-266

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combined Inhibition of Tumor Necrosis Factor α and Interleukin‐17 As a Therapeutic Opportunity in Rheumatoid Arthritis: Development and Characterization of a Novel Bispecific Antibody

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 1, 2015-01 ,pp. : 51-62

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of Methotrexate, Anti–Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta‐Analysis

ARTHRITIS CARE AND RESEARCH, Vol. 66, Iss. 7, 2014-07 ,pp. : 1016-1026

John Wiley & Sons Inc

Access to resources Recommend Favorite

Total cholesterol, lipoprotein, and triglyceride levels in tumor necrosis factor inhibitor‐treated patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 11-9059, Iss. 10, 2015-10 ,pp. : e442-e445

John Wiley & Sons Inc

Access to resources Recommend Favorite

Total cholesterol, lipoprotein, and triglyceride levels in tumor necrosis factor inhibitor‐treated patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 10, 2015-10 ,pp. : e442-e445

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tumour necrosis factor-α, interleukin-2 soluble receptor and different inflammatory parameters in patients with rheumatoid arthritis

By Fröde Tânia Silvia Tenconi Patrícia Debiasi Marilei Reynaud Medeiros Yara Santos

Mediators of Inflammation, Vol. 11, Iss. 6, 2002-12 ,pp. : 345-349

Informa Healthcare

Access to resources Recommend Favorite